Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Rhabdomyolysis following interferon-beta treatment in a patient with multiple sclerosis - A case report.
Application of the 2012 revised diagnostic definitions for paediatric multiple sclerosis and immune-mediated central nervous system demyelination disorders.
Absence of MxA induction is related to a poor clinical response to interferon beta treatment in multiple sclerosis patients.
Neurosarcoidosis: Clinical Features, Diagnosis, and Management.
Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy.
Novel p75 neurotrophin receptor ligand stabilizes neuronal calcium, preserves mitochondrial movement and protects against HIV associated neuropathogenesis.
Nerve ultrasound protocol in differentiating chronic immune-mediated neuropathies.
The relationship between the rate of brain volume loss during first 24 months and disability progression over 24 and 48 months in relapsing MS.
Cost-Utility Analysis of Natalizumab as First-Line Treatment of Highly-Active Relapsing-Remitting Multiple Sclerosis in the Brazilian Public Healthcare System.
Fatigue and heat sensitivity in patients with multiple sclerosis.
[Symptoms and neurological findings in patients with multiple sclerosis].
Icariin has synergistic effects with methylprednisolone to ameliorate EAE via modulating HPA function, promoting anti-inflammatory and anti-apoptotic effects.
A systematic methodology for large scale compound screening: A case study on the discovery of novel S1PL inhibitors.
Therapy of NMO spectrum disorders.
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study.
The Protective Role of HLA-DRB1(∗)13 in Autoimmune Diseases.
Demyelinating diseases in Asia.
Fingolimod Real World Experience: Efficacy and Safety in Clinical Practice.
Inhibin-a immunoreactivity in nervous system lesions.
A Novel Asp121Asn Mutation of Myelin Protein Zero Is Associated with Late-Onset Axonal Charcot-Marie-Tooth Disease, Hearing Loss and Pupil Abnormalities.
A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.
Bypassing hazard of housekeeping genes: their evaluation in rat granule neurons treated with cerebrospinal fluid of multiple sclerosis subjects.
Acute demyelinating lesions with restricted diffusion in multiple sclerosis.
Youth and environmental enrichment generate serum exosomes containing miR-219 that promote CNS myelination.
Clinical and epidemiological profiles of non-traumatic myelopathies.
Pages
« first
‹ previous
…
675
676
677
678
679
680
681
682
683
…
next ›
last »